Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

Following the patent expiry of Novo Nordisk’s semaglutide on March 20, 2026, Indian drugmakers including Natco, Dr. Reddy’s, ...

Foreign substances, including black particles and a gel-like mass, were reportedly found in the over-the-counter children's ...

Guardian, which at the end of last year had 61 pharmacies across 38 states, said the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 900,000 shares ...

Guardian Pharmacy Services, Inc. ("Guardian") (NYSE: GRDN) today announced the pricing of its upsized underwritten public offering (the "Offering") of 6,000,000 shares of its Class A common stock at a ...

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common StockThe Associated ...

Tesla, Inc. rated Sell: lofty valuation vs execution risks, shrinking margins, and rising EV/robotaxi competition. Click for ...

Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but ...

Caribou Biosciences offers the strongest allogeneic CAR-T data to date, with efficacy and safety. Read why I am bullish about ...